Zoetis Inc. (ZTS) suffered a pre-market plunge of 7.41% on Thursday, as the animal healthcare company's 2025 profit and revenue forecasts fell short of Wall Street estimates.
Zoetis projected adjusted earnings per share for 2025 to be between $6.00 and $6.10, missing analysts' average estimate of $6.29. The company also guided for full-year revenue in the range of $9.23 billion to $9.38 billion, lower than the consensus estimate of $9.57 billion. The disappointing outlook was partly attributed to the impact of a stronger dollar and the divestiture of certain product portfolios.
Despite the weak guidance, Zoetis reported better-than-expected results for the fourth quarter. Adjusted earnings of $1.40 per share exceeded expectations of $1.34, while revenue rose 5% year-over-year to $2.32 billion, slightly above estimates. However, the market's focus appears to be on the company's muted outlook for 2025, leading to the steep pre-market decline.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.